Presentation TCT 2015 PCI and Atrial Fibrillation Anticoagulation: Triple or Dual Therapy? Presenter: George D. Dangas, Paul A. Gurbel, C. Michael Gibson October 13, 2015
Presentation TCT 2015 Anticoagulation in the Periimplant Period (Pre, Peri, and Post): An Evidence-Based Analysis Presenter: Maurice Buchbinder, Brian K. Whisenant, Sameer Gafoor October 12, 2015
Presentation TCT 2015 The Clinical Impact of Stroke With 2 Preventative Strategies: LAA Closure vs Chronic Oral Anticoagulation Presenter: Reda Ibrahim, Matthew J. Price, Vivek Y. Reddy October 11, 2015
Presentation TCT 2015 Debate: Is LAA Closure an Alternative to Oral Anticoagulation in Low Bleeding Risk Patients? Yes, LAA Closure Is at Least as Good as Oral Anticoagulation! Presenter: Reda Ibrahim, Matthew J. Price, Saibal Kar October 11, 2015
Presentation TCT 2015 Debate: Is LAA Closure an Alternative to Oral Anticoagulation in Low Bleeding Risk Patients? No, It Should Be Limited to Anticoagulation Contraindicated Patients! Presenter: Reda Ibrahim, Matthew J. Price, Jai-Wun Park October 11, 2015
Presentation TCT 2015 Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation Presenter: David R. Holmes Jr., Vivek Y. Reddy, Piera Capranzano October 11, 2015
Presentation TCT 2015 Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation Presenter: David R. Holmes Jr., Vivek Y. Reddy, Neal S. Kleiman October 11, 2015
News Conference News TCT 2015 Use of LAA Occlusion in Low-Risk Patients Debated Todd Neale October 11, 2015
News Conference News TCT 2015 Cath Lab Economics: Pursuit of a Light at the End of the Tunnel Nicole Lou October 11, 2015
News Conference News TCT 2014 Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation Todd Neale October 10, 2014
Presentation TCT 2014 Anticoagulation After LAA Closure in Anticoagulation Eligible and Ineligible Patients Presenter: Ted E. Feldman, Saibal Kar, Zoltan G. Turi, Jacqueline Saw September 16, 2014
Presentation TCT 2014 TCT 171: Avoidance of Major Bleeding with WATCHMAN Left Atrial Appendage Closure Compared with Long-term Oral Anticoagulation: A Pooled Analysis of Randomized Trials Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Matthew J. Price September 15, 2014
Presentation TCT 2014 LARIAT Experience in Patients Contraindicated to Anticoagulation Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Sameer Gafoor September 15, 2014
Presentation TCT 2014 Yes, It Is a Good Option for Most Anticoagulation Eligible Patients Presenter: Saibal Kar September 15, 2014
Presentation TCT 2014 The REG1 Anticoagulation System: Factor IX Inhibitor Using RNA Aptamer Technology Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, A. Michael Lincoff September 15, 2014
Presentation TCT 2014 No, It Should Be Limited to Patients with Absolute Anticoagulation Contraindications Presenter: Jai-Wun Park September 15, 2014
Presentation TCT 2014 PCI and Anticoagulation: Triple Therapy Presenter: Jurrien M. Ten Berg September 13, 2014
News Conference News TCT 2014 Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES Todd Neale September 13, 2014
Presentation TCT 2013 Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens Presenter: Harvey White October 31, 2013
Presentation TCT 2013 Case #1: Fibrinolysis or Aggressive Pre-hospital Anticoagulation to Prevent Complications During Long Distance Transfer? Presenter: Peter Clemmensen October 31, 2013